Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Remyelination after Lysophosphatidyl Choline-Induced Demyelination Is Stimulated by Bone Marrow Stromal Cell-Derived Oligoprogenitor Cell Transplantation.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Neuroprotection With Phenytoin in Optic Neuritis
Glycans of myelin proteins.
Spinal cord injury is related to an increased risk of multiple sclerosis: a population-based, propensity score-matched, longitudinal follow-up study.
Neuroendocrine Immunoregulation in Multiple Sclerosis.
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction.
Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.
Aquaporins: important but elusive drug targets.
CNS diseases and uveitis.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Acute exacerbation of multiple sclerosis presenting with facial metamorphopsia and palinopsia.
Scoring treatment response in patients with relapsing multiple sclerosis.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Clinical application of susceptibility weighted imaging: exploring from routine service.
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.
Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS.
History, applications, and mechanisms of deep brain stimulation.
Pages
« first
‹ previous
…
231
232
233
234
235
236
237
238
239
…
next ›
last »